1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Economia
  4. Articles publicats en revistes (Economia)
Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/175433
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRomero Gómez, Manuel 1967--
dc.contributor.authorKachru, Nandita-
dc.contributor.authorAscanio, Meritxell-
dc.contributor.authorDarbà, Josep-
dc.contributor.authorShreay, Sanatan-
dc.date.accessioned2021-03-19T12:20:02Z-
dc.date.available2021-03-19T12:20:02Z-
dc.date.issued2020-12-11-
dc.identifier.issn0025-7974-
dc.identifier.urihttp://hdl.handle.net/2445/175433-
dc.description.abstractThe rising prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) presents many public health challenges, including a substantial impact on healthcare resource utilization and costs. There are important regional differences in the burden of NAFLD/NASH, and Spain-specific data are lacking. This retrospective, observational study examined the impact of liver disease severity, comorbidities, and demographics on healthcare resource utilization and costs in Spain (...)-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherLippincott, Williams & Wilkins. Wolters Kluwer Health-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1097/MD.0000000000023506-
dc.relation.ispartofMedicine, 2020, vol. 99, num. 50, p. e23506-
dc.relation.urihttps://doi.org/10.1097/MD.0000000000023506-
dc.rightscc-by (c) Romero Gómez, Manuel 1967- et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Economia)-
dc.subject.classificationCost de l'assistència sanitària-
dc.subject.classificationGestió hospitalària-
dc.subject.classificationHepatitis-
dc.subject.classificationMalalties del fetge-
dc.subject.otherCost of medical care-
dc.subject.otherHospital administration-
dc.subject.otherHepatitis-
dc.subject.otherLiver diseases-
dc.titleDisease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec705274-
dc.date.updated2021-03-19T12:20:02Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
705274.pdf464.72 kBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons